These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2114928)

  • 1. The effect of DNA polymerase inhibitors on the cytotoxicity of cisplatin in human ovarian carcinoma cells.
    Katz EJ; Andrews PA; Howell SB
    Cancer Commun; 1990; 2(4):159-64. PubMed ID: 2114928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of significant modulation of the formation and removal of platinum-DNA adducts by aphidicolin glycinate in two logarithmically-growing ovarian tumour cell lines in vitro.
    Dempke WC; Shellard SA; Fichtinger-Schepman AM; Hill BT
    Carcinogenesis; 1991 Mar; 12(3):525-8. PubMed ID: 1901253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single step selection of cis-diamminedichloroplatinum(II) resistant mutants from a human ovarian carcinoma cell line.
    McLaughlin K; Stephens I; McMahon N; Brown R
    Cancer Res; 1991 Apr; 51(8):2242-5. PubMed ID: 1901242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of DNA excision by DNA polymerase-alpha inhibitor in UV-damaged HeLa cells.
    Joe CO; Lee MA; Choi BS; Kang KW
    Toxicol Lett; 1990 Aug; 52(3):253-9. PubMed ID: 2117783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II).
    Masuda H; Tanaka T; Matsuda H; Kusaba I
    Cancer Res; 1990 Mar; 50(6):1863-6. PubMed ID: 2306738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of aphidicolin glycinate alone or in combination with cisplatin in a murine ovarian tumor resistant to cisplatin.
    Damia G; Tagliabue G; Zucchetti M; Davoli E; Sessa C; Cavalli F; D'Incalci M
    Cancer Chemother Pharmacol; 1992; 30(6):459-64. PubMed ID: 1394802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells.
    Mann SC; Andrews PA; Howell SB
    Int J Cancer; 1991 Jul; 48(6):866-72. PubMed ID: 1713575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of Topo II alpha gene expression and reversing of drug resistance in multi-drug resistant epithelial ovarian cancer cells induced by RNA interference in vitro].
    He J; Li L; Tang BJ; Zhang W; Li DR; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):686-90. PubMed ID: 20079182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines.
    Lai GM; Ozols RF; Young RC; Hamilton TC
    J Natl Cancer Inst; 1989 Apr; 81(7):535-9. PubMed ID: 2493524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel and SN-38 overcome cisplatin resistance of ovarian cancer cell lines by down-regulating the influx and efflux system of cisplatin.
    Komuro Y; Udagawa Y; Susumu N; Aoki D; Kubota T; Nozawa S
    Jpn J Cancer Res; 2001 Nov; 92(11):1242-50. PubMed ID: 11714450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines.
    Masuda H; Ozols RF; Lai GM; Fojo A; Rothenberg M; Hamilton TC
    Cancer Res; 1988 Oct; 48(20):5713-6. PubMed ID: 3139281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA polymerase zeta accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost DNA mismatch repair.
    Lin X; Trang J; Okuda T; Howell SB
    Clin Cancer Res; 2006 Jan; 12(2):563-8. PubMed ID: 16428501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple effects of 3-aminobenzamide on DNA damage induced by cisplatin (DDP) in DDP-sensitive and -resistant rat ovarian tumor cell lines.
    Chen G; Zeller WJ
    Cancer Lett; 1992 Oct; 67(1):27-33. PubMed ID: 1423242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of thaliblastine on cytotoxicity and DNA damage in drug-sensitive and -resistant rat ovarian tumor cells treated with cisplatin.
    Chen G; Zeller WJ
    Anticancer Res; 1993; 13(1):219-23. PubMed ID: 8476216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line.
    Fajac A; Da Silva J; Ahomadegbe JC; Rateau JG; Bernaudin JF; Riou G; Bénard J
    Int J Cancer; 1996 Sep; 68(1):67-74. PubMed ID: 8895543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of repaired sites in human DNA synthesized in the presence of inhibitors of DNA polymerases alpha and beta in human fibroblasts.
    Cleaver JE
    Biochim Biophys Acta; 1983 Apr; 739(3):301-11. PubMed ID: 6403037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleotide excision repair in the human ovarian carcinoma cell line (2008) and its cisplatin-resistant variant (C13*).
    Moorehead RA; Armstrong SG; Rainbow AJ; Singh G
    Cancer Chemother Pharmacol; 1996; 38(3):245-53. PubMed ID: 8646799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
    Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.
    Terheggen PM; Emondt JY; Floot BG; Dijkman R; Schrier PI; den Engelse L; Begg AC
    Cancer Res; 1990 Jun; 50(12):3556-61. PubMed ID: 2340504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.